Sericin peptide with alpha-glycosidase inhibiting activity as well as preparation and application thereof
A technology of glycosidase inhibition and sericin peptide, which is applied in application, medical preparations containing active ingredients, peptides, etc., can solve problems such as liver damage, and achieve the effect of lowering postprandial blood sugar and inhibiting the activity of α-glucosidase.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Preparation of a sericin peptide with α-glucosidase inhibitory activity:
[0047] Wherein, the sericin peptide having α-glucosidase inhibitory activity has the amino acid sequence shown in SEQ ID No:1. Its preparation steps are as follows:
[0048] (1) Weigh n equivalents of resin into the reactor, add DCM to swell for half an hour, then remove the DCM, add 2n equivalents of the first amino acid in the sequence, add 2n equivalents of DIEA, appropriate amount of DMF, DCM (appropriate amount means It is advisable to fully agitate the resin), nitrogen bubbling reaction for 60min. Then add about 5n equivalent of methanol, react for half an hour, remove the reaction solution, and wash with DMF and MEOH;
[0049](2) Add the second amino acid in the sequence (also 2n equivalents), 2n equivalents of HBTU and DIEA to the reactor, react with nitrogen gas bubbling for half an hour, wash off the liquid, detect ninhydrin, and then seal with pyridine and acetic anhydride end. Fin...
Embodiment 2
[0055] Elution and purity determination of synthetic sericin peptide:
[0056] Take a little crude peptide that has been completely synthesized, and dissolve the sample with 10% acetonitrile solution containing 0.1% (v / v) TFA. The gradient elution of phase B from 15% to 48% was carried out as the eluent of 0.1% TFA aqueous solution and 0.1% TFA acetonitrile solution. Such as figure 1 As shown, the sericin peptide synthesized by the present invention has an elution peak with a molecular size of 1379.36Da, and its retention time is 7.752min.
[0057] Take the eluted main peak sample for mass spectrometry, and determine the sample purity according to the required sample molecular weight 1379.36 and the relative area content of the main peak, such as figure 2 As shown, the purity of the synthesized sericin peptide synthesized by the present invention can reach 99.11% through purification.
[0058] When the purity of the peptide reaches above 99%, the secondary preparation and ...
Embodiment 3
[0060] Synthetic sericin peptide inhibits α-glucosidase activity assay:
[0061] Reagents: α-glucosidase (EC 3.2.1.20, 19.3units / mg) was purchased from Saccharomyces cerevisiae and purchased from Sigma-Aldrich Company in the United States; pNPG (p-nitrophenyl-β-D-galactopyranoside) was purchased from the United States Sigma-Aldrich Company; other reagents are analytically pure; the biologically active polypeptide synthesized in Example 1.
[0062] Experimental principle: α-glucosidase catalyzes pNPG to produce p-nitrophenol, which has a characteristic absorption peak at 405nm, so we use the kinetic / time software of the UV spectrophotometer to measure the UV absorption peak at 405nm, which can be displayed digitally The biologically active polypeptide synthesized in Example 1 inhibits the effect of α-glucosidase.
[0063] At 37°C, in a phosphate (0.05mol / L) buffer system of pH 6.8, 200μL α-glucosidase (0.175U / ml) and 100μL sericin peptide at different concentrations were incub...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com